# US 2003/0202997 A1 · Methods and compositions for treating ectoparasite infestation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0202997 A1
- Document ID: US20030202997A1
- Status: Published application
- Kind: A1
- Application number: 10/136,075
- Filed: 2002-04-29
- Published: 2003-10-30
- Earliest claimed: 2002-04-29
- Assignees: Piedmont Pharmaceuticals, LLC
- Inventors: William R. Campbell; Kathleen G. Palma; Neil E. Paulsen
- Web page: https://patentgrep.com/patent/US20030202997A1

## CPC

- A01N 25/32: Ingredients for reducing the noxious effect of the active substances to organisms other than pests, e.g. toxicity reducing compositions, self-destructing compositions
- A01N 25/006: {insecticidal}
- A01N 25/04: Dispersions, {emulsions, suspoemulsions, suspension concentrates} or gels (foams A01N25/16)
- A01N 37/02: Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A61K 31/23: of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K 31/695: Silicon compounds
- A61P 33/14: Ectoparasiticides, e.g. scabicides
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Compositions and methods for killing ectoparasites on a subject. Compositions containing a fatty acid ester, e.g., isopropyl myristate, effective for killing ectoparasites is described. Also described are compositions containing a fatty acid ester and a siloxane (e.g. decacyclomethicone). The compositions can also contain a mectin and/or a mycin, and S-methoprene. The compositions are useful against a variety of ectoparasites that afflict humans, animals, and plants, e.g., head lice, fleas, body lice, crab lice, scabies, ticks, and plant parasites.

## Claims

### Claim 1

A method of killing ectoparasites on a subject comprising:
topically administering to an area on the subject where ectoparasites are present a composition comprising a fatty acid ester;
wherein the fatty acid ester is provided in an amount of between 25% and 70% w/w; and
wherein the composition does not comprise any other agent in an amount effective for killing ectoparasites present.

### Claim 2 (depends on 1)

The method of claim 1 wherein the ectoparasites are selected from the group consisting of: lice, ticks, and fleas.

### Claim 3 (depends on 2)

The method of claim 2 wherein the subject is a mammal.

### Claim 4 (depends on 3)

The method of claim 3 wherein the mammal is a human and the ectoparasites are head lice.

### Claim 5 (depends on 3)

The method of claim 3, wherein the composition further comprises a siloxane.

### Claim 6 (depends on 5)

The method of claim 5 wherein the siloxane is selected from the group consisting of: decacyclomethicone, octamethylcyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, and cyclohexasiloxane.

### Claim 7 (depends on 6)

The method of claim 6 wherein the siloxane is decacyclomethicone.

### Claim 8 (depends on 3)

The method of claim 3 wherein the fatty acid ester is selected from the group consisting of esters of: myristate, laurate, palmitate, and stearate.

### Claim 9 (depends on 8)

The method of claim 8 wherein the fatty acid ester is isopropyl myristate.

### Claim 10 (depends on 5)

The method of claim 5 wherein the siloxane is decacyclomethicone and the fatty acid ester is isopropyl myristate.

### Claim 11 (depends on 10)

The method of claim 10 wherein the composition further comprises S-methoprene.

### Claim 12 (depends on 4)

The method of claim 4 wherein the ectoparasite is selected from the group consisting of: body lice, crab lice, scabies, and ticks.

### Claim 13 (depends on 10)

The method of claim 10 wherein the mammal is a human and the ectoparasite is head lice.

### Claim 14

A method of killing ectoparasites on a subject comprising, topically administering to an area on the subject where ectoparasites are present a composition comprising
at least 30% w/w siloxane;
a fatty acid ester; and
a mectin and/or a mycin;
wherein the siloxane, fatty acid ester, and mectin and/or mycin are provided in amounts sufficient to kill ectoparasites present; and
wherein the composition does not comprise any other agent in an amount effective for killing ectoparasites present.

### Claim 15 (depends on 14)

The method of claim 14 wherein the ectoparasites are selected from the group consisting of: lice, ticks and fleas.

### Claim 16 (depends on 15)

The method of claim 15 wherein the subject is a mammal.

### Claim 17 (depends on 16)

The method of claim 16 wherein the mammal is a human and the ectoparasites are head lice.

### Claim 18 (depends on 16)

The method of claim 16 wherein the siloxane is selected from the group consisting of: decacyclomethicone, octamethylcyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, and cyclohexasiloxane; and
the fatty acid ester is selected from the group consisting of: myristate, laurate, palmitate, and stearate.

### Claim 19 (depends on 18)

The method of claim 18 wherein the siloxane is decacyclomethicone, the fatty acid ester is isopropyl myristate and is provided in a concentration of between 25% and 70% w/w, the mectin is ivermectin, and the mycin is milbemycin.

### Claim 20 (depends on 19)

The method of claim 19 wherein the composition further comprises S-methoprene.

### Claim 21 (depends on 14)

The method of claim 14 wherein the ectoparasites are selected from the group consisting of: body lice, crab lice, and scabies.

### Claim 22 (depends on 19)

The method of claim 19 wherein the mammal is a human and the ectoparasites are head lice.

### Claim 23

A method of manufacturing a medicament for killing ectoparasites on a subject, comprising,
providing a medicament comprising a fatty acid ester at a concentration of between 25% and 70% w/w and in an amount sufficient to kill ectoparasites and when the medicament is applied to an area on the subject where ectoparasites are present;
wherein the medicament does not comprise any other agents effective for killing ectoparasites when topically applied to a treated subject.

### Claim 24 (depends on 23)

The method of claim 23 wherein the ectoparasites are selected from the group consisting of: lice, ticks, and fleas.

### Claim 25 (depends on 24)

The method of claim 24 wherein the subject is a mammal.

### Claim 26 (depends on 25)

The method of claim 25 wherein the mammal is a human and the ectoparasites are head lice.

### Claim 27 (depends on 25)

The method of claim 25 wherein the medicament further comprises a siloxane.

### Claim 28 (depends on 27)

The method of claim 27 wherein the siloxane is selected from the group consisting of: deca-cyclomethicone, octa-methylcyclomethicone, cyclo-tetrasiloxane, cyclo-pentasiloxane, and cyclo-hexasiloxane.
the fatty acid ester is selected from the group consisting of: myristate, laurate, palmitate, and stearate.

### Claim 29 (depends on 27)

The method of claim 27 wherein the siloxane is decacyclomethicone and the fatty acid ester is isopropyl myristate.

### Claim 30 (depends on 25)

The method of claim 25 wherein the fatty acid ester is isopropyl myristate.

### Claim 31 (depends on 29)

The method of claim 29 wherein the composition further comprises a mectin and/or a mycin.

### Claim 32 (depends on 29)

The method of claim 29 wherein the composition further comprises S-methoprene.

### Claim 33

A composition for killing ectoparasites comprising,
a fatty acid ester; and
at least 20% siloxane;
wherein the composition does not contain any other agent in an amount effective for killing ectoparasites present.

### Claim 34 (depends on 33)

The composition of claim 33 wherein the fatty acid ester is isopropyl myristate.

### Claim 35 (depends on 34)

The composition of claim 34 wherein comprises at least 80% decacyclomethicone.

### Claim 36 (depends on 33)

The composition of claim 33 wherein the fatty acid ester is isopropyl myristate present at between 45% and 55% w/w, the siloxane is present at between 45% and 55% w/w.

### Claim 37 (depends on 36)

The composition of claim 36 wherein the siloxane contains at least 80% decacyclomethicone.

### Claim 38 (depends on 33)

The composition of claim 33 further comprising a mectin and/or a mycin.

### Claim 39 (depends on 33)

The composition of claim 33 further comprising S-methoprene.

### Claim 40

A kit for treating ectoparasite infestations comprising,
a composition comprising
a fatty acid ester present at an amount less than 70% w/w;
a siloxane; and
wherein the composition does not contain any other agent in an amount effective for killing ectoparasites present; and
instructions describing how to use the items included in the kit to kill ectoparasites.

### Claim 41 (depends on 39)

The kit of claim 39 wherein the siloxane is cyclomethicone and the fatty acid ester is isopropyl myristate.

### Claim 42 (depends on 40)

The kit of claim 40 wherein the composition further comprises a mectin and/or a mycin.

### Claim 43 (depends on 40)

The composition of claim 40 further comprising S-methoprene.

### Claim 44 (depends on 40)

The kit of claim 40 further comprising a nit comb.
